# Evolocumab Pregnancy Exposure Registry

> **NCT02957604** · — · TERMINATED · sponsor: **Amgen** · enrollment: 140 (actual)

## Conditions studied

- Hypercholesterolemia; ASCVD; Pregnancy

## Interventions

- **DRUG:** evolocumab

## Key facts

- **NCT ID:** NCT02957604
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2016-12-22
- **Primary completion:** 2020-09-02
- **Final completion:** 2020-09-02
- **Target enrollment:** 140 (ACTUAL)
- **Last updated:** 2020-12-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02957604

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02957604, "Evolocumab Pregnancy Exposure Registry". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02957604. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*